ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

VHIO’s Josep Tabernero and Francesc Bosch among the Forbes pick of 100

10/12/2019|Comments Off on VHIO’s Josep Tabernero and Francesc Bosch among the Forbes pick of 100

VHIO’s Running for Research: proud promoters of cancer research at AECC’s Barcelona-based runathon

05/12/2019|Comments Off on VHIO’s Running for Research: proud promoters of cancer research at AECC’s Barcelona-based runathon

Gene-targeted olaparib delivers powerful blows against BRCA1/2 mutated prostate cancer

04/12/2019|Comments Off on Gene-targeted olaparib delivers powerful blows against BRCA1/2 mutated prostate cancer

VHIO investigators establish ‘user-friendly’ criteria to capture hyperprogression in patients treated with immune checkpoint inhibitors

02/12/2019|Comments Off on VHIO investigators establish ‘user-friendly’ criteria to capture hyperprogression in patients treated with immune checkpoint inhibitors

See all news
BROWSE OUR PIs
Launch our Scientific Report 2018

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

Follow us:

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’s ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’s IMMUNOTHERAPY
& IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO -”la Caixa” Scientific Seminars Series –
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS